Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Lilly is considering expanding the availability of lower-priced vials of its blockbuster obesity drug Zepbound ...

The Justice Department is rescinding its protocol for federal executions that allowed for single-drug lethal injections with ...

Medicare drug plans can now cover Eli Lilly & Co.’s obesity drug Zepbound as a treatment for obstructive sleep apnea, news that’s expected to prove a big boost for the drug company.